Research Article
Discriminatory Value of Adiponectin to Leptin Ratio for COVID-19 Pneumonia
Table 1
Patient general characteristics.
| | Variables | Controls (n = 36) | COVID-19 patients (n = 48) | value |
| | Gender | | | | | Male | 23 (63.90%) | 34 (70.80%) | 0.50 | | Female | 13 (36.10%) | 14 (29.20%) | | | Age (years) | | | | | Median (min-max) | 59.50 (36–82) | 63.50 (34–88) | 0.07 | | BMI (kg/m2) | | | | | Median (min-max) | 28.95 (19.14–45) | 29.51 (20.76–41.03) | 0.79 | | BMI <25 | 6 (16.67%) | 10 (20.83%) | 0.48 | | M/F | 3/3 (50%; 50%) | 6/4 (60%; 40%) | 0.70 | | Median (min-max) | 24 (19.14–24.69) | 23.52 (20.76–24.80) | | | 25< BMI <30 | 14 (38.89%) | 16 (33.33%) | 0.31 | | M/F | 11/3 (78.60%; 21.40%) | 14/2 (87.50%; 12.50%) | 0.51 | | Median (min-max) | 27.34 (25–29.40) | 27.78 (25.95–29.76) | | | BMI >30 | 16 (44.44%) | 22 (45.84%) | 0.16 | | M/F | 9/7 (56.20%; 43.80%) | 14/8 (63.60%; 36.40%) | 0.65 | | Median (min-max) | 31.85 (30.50–45) | 32.93 (30.12–41.03) | | | Metabolic syndrome (yes) | 16 (44.40%) | 15 (31.20%) | 0.22 |
|
|
BMI is for body mass index.
|
